Back to mobile site

Mizuho Starts Castle Biosciences (CSTL) at Outperform

October 29, 2026 5:38 AM EDT Send to a Friend
Mizuho analyst Bradley Bowers initiates coverage on Castle Biosciences (NASDAQ: CSTL) with a Outperform rating and a price target of ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login